Islamabad: During the last three years, 1,018 FIRs have been lodged and fines worth Rs203.63 million charged to culprits involved in the business of counterfeit, spurious and falsified drugs, the CEO of the Drug Regulatory Authority Pakistan Aslam Afghani informed the media here Thursday.“Around 53,371 samples were collected and analysed and a cumulative fine of Rs203.63 million imposed, with 1,018 FIRs launched against culprits during 2015-2017,” Aslam Afghani stated at a press...